Skip to product information

Harvard 31st Annual Update in Neurology 2023

Harvard 31st Annual Update in Neurology 2023

Regular price $50.00 USD
Regular price $50.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Harvard 31st Annual Update in Neurology 2023

Harvard 31st Annual Update in Neurology 2023

Regular price $50.00
Regular price $50.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Harvard 31st Annual Update in Neurology 2023

    Harvard 31st Annual Update in Neurology 2023 (Videos) This program provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, and recent advances, including the use of genetic tests, optimal use of imaging, new approaches for diagnosis, and expanded options for treatment for a wide array of neurological diseases.

    • #Harvard 31st Annual Update in #Neurology 2023 (Videos)

    • Format : 70 Videos + PDFs

      File Size : 31.54 GB

      • Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions. As updates are presented, they are paired with specific practice recommendations to help you optimize patient care and outcomes.

      Who Should Attend

      • Physicians
      • Physician Assistants
      • Nurses
      • Nurse Practitioners

      Learning Objectives

      Upon completion of this activity, participants will be able to:

      • Apply updated research and guidelines for common neurological conditions in their care of patients.
      • Explain the principles of delivering neurological care in resource constrained environments.
      • Recognize immune mediated neurological diseases and initiate appropriate therapy.
      • Identify the most common causes of cognitive error in the diagnosis and treatment of neurological diseases.
      • Define types of seizures and mimickers of seizures.
      • Recognize and treat common and uncommon headache disorders and dizziness.
      • Summarize how to effectively prevent and manage stroke.
      • Develop strategies for diagnosing and treating complicated neurologic problems in the outpatient and inpatient settings.
        Program :

       

      Monday, October 9, 2023

      DAY ONE

      Introduction

      • Updates in Alzheimer's Disease
        Dennis J. Selkoe, MD
      • Q&A
      • State-of-the Art Approaches to the Diagnosis of Dementia
        Scott M. McGinnis, MD
      • Q&A
      • State-of-the-Art Approaches in the Treatment of Dementia
        Seth A. Gale, MD
      • Q&A
      • State-of-the-Art Diagnosis of Demyelinating Disease, MS, NMOSD, and MOGAD
        Tanuja Chitnis, MD
      • Q&A
      • Coma and Disorders of Consciousness*
        Martin A. Samuels, MD
      • Q&A
      • Updates in the Diagnosis and Medical Management of Parkinsonism
        Albert Y. Hung, MD, PhD
      • Q&A
      • Non-Pharmacologic Therapy of Movement Disorders
        Michael T. Hayes, MD
      • Q&A
      • Advances in Our Understanding of Hyperkinetic Movements
        Edison K. Miyawaki, MD
      • Q&A with Course Directors
        Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

      Tuesday, October 10, 2023

      DAY TWO

      • Concussion and Sports-related Neurological Injuries: Guidance to Improve Patient Outcomes
        Claus Reinsberger, MD
      • Q&A
      • ‘Visual Disturbances
        Sashank Prasad, MD
      • Q&A
      • State-of-the-Art Approaches in Stroke Prevention and Treatment Prevention and Treatment
        Mariel G. Kozberg, MD, PhD
      • Q&A
      • Updates in Genetics of Cerebrovascular Disease
        Patricia L. Musolino, MD, PhD
      • Q&A
      • Current Approach to Myopathies
        Vijay S. Ganesh, MD, PhD
      • Q&A
      • Keynote: How Neurologists Think: What My Errors Taught Me*
        Martin A. Samuels, MD
      • Q&A
      • Neurologic Emergencies: Quick Identification and Steps to Optimize Patient Outcomes
        Bradley J. Molyneaux, MD, PhD
      • Q&A
      • Brain Tumors in 2023: State-of-the-Art and Emerging Treatment Options
        Tracy T. Batchelor, MD, MPH
      • Q&A with Course Directors
        Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

      Wednesday, October 11, 2023

      DAY THREE

      • Best Practices for Diagnosing and Managing Psychogenic Non-Epileptic Seizures
        Barbara A. Dworetzky, MD
      • Q&A
      • Challenging Epilepsy Cases in Pregnancy
        Paula Emanuela Voinescu, MD
      • Q&A
      • Updates in Pharmacological Treatment of Epilepsy
        Jong Woo Lee, MD, PhD
      • Q&A
      • New Concepts in Non-Pharmacologic Treatment of Epilepsy
        Ellen J. Bubrick, MD
      • Q&A
      • Studying Functional Networks and Targeting Stimulation Treatment of Neuropsychiatric Diseases
        Michael D. Fox, MD, PhD
      • Q&A
      • Neurogenetics and Impact on Clinical Practice
        Scott R. Plotkin, MD, PhD
      • Q&A
      • Below-the-Belt Neurology: Bladder, Bowel & Sexual Dysfunction
        Tamara Kaplan, MD
      • Q&A
      • Keynote: State-of-the-Art Treatment of ALS
        James D. Berry, MD, MPH
      • Q&A with Course Directors
        Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

      Thursday, October 12, 2023

      DAY FOUR

      • Neurological Complications of Checkpoint Inhibition and Other Immunotherapies in Cancer Patients
        Isabel Arrillaga-Romany, MD, PhD
      • Q&A
      • Evolving Uses of Imaging in Neurology
        Joshua P. Klein, MD, PhD
      • Q&A
      • Optimizing Your Approach to Treating Multiple Sclerosis
        Eric C. Klawiter, MD
      • Q&A
      • Modern Diagnosis and Treatment of Cerebellar Ataxias
        Jeremy D. Schmahmann, MD
      • Q&A
      • Update on Diagnosing and Treating Eye Movement Disorders
        Robert M. Mallery, MD
      • Q&A
      • Neurology of Skull Base Lesions
        Bart K. Chwalisz, MD
      • Q&A
      • Treating Neurological Cancer
        Eudocia Quant Lee, MD, MPH
      • Q&A
      • Alcohol Associated Neurological Disorders
        Michael E. Charness, MD
      • Q&A with Course Directors
        Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

      Friday, October 13, 2023

      DAY FIVE

      • Neuropathy and Neuromuscular Junction: Cases Offering Clinical Pearls
        Christopher T. Doughty, MD
      • Q&A
      • Updates in the Neurologic Impact of COVID
        Giovanna S. Manzano, MD
      • Q&A
      • Contemporary Issues in Women's Neurology
        Mary Angela O'Neal, MD
      • Q&A
      • Neuroprognotication, Coma and Recovery
        Michael J. Young, MD
      • Q&A
      • Unusual and Difficult Cases of Headache-Diagnostic Challenges
        Brian E. McGeeney, MD, MPH, MBA
      • Q&A
      • Delivering the Best Care for Neck and Back Pain
        Shamik Bhattacharyya, MD
      • Q&A
      • New Treatment Options for Migraine
        Elizabeth W. Loder, MD, MPH
      • Q&A
      • Treating Headache with Integrative Therapies
        Carolyn A. Bernstein, MD
      • Lessons in Global Neurology
        Farrah J. Mateen, MD, PhD
      • Q&A with Course Directors
        Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD